Kronos Bio Announces Participation in the Jefferies Virtual Healthcare Conference

San Mateo, Calif., and Cambridge, Mass., May 26, 2020 – Kronos Bio, Inc., dedicated to drugging transcriptional regulatory networks in cancer, today announced that Norbert Bischofberger, Ph.D., President and Chief Executive Officer will present at the Jefferies Virtual Healthcare Conference taking place June 2-4, 2020.

Presentation Date: Wednesday, June 3, 2020
Presentation Time: 4:30 PM ET

A webcast will be made available on the Company’s website at in the News and Events section. Following the live audio webcast, a replay will be available on the Company’s website for approximately 30 days.

About Kronos Bio, Inc.

Kronos Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription.

For more information, please visit or follow the company on LinkedIn.

# # #


Investor Contact:
Dr Yasir Al-Wakeel
CFO & Head of Corporate Development

Media Contact:
Sheryl Seapy
W2O pure
+1 213-262-9390